These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

352 related items for PubMed ID: 12297840

  • 1. P53 gene and Wnt signaling in benign neoplasms: beta-catenin mutations in hepatic adenoma but not in focal nodular hyperplasia.
    Chen YW, Jeng YM, Yeh SH, Chen PJ.
    Hepatology; 2002 Oct; 36(4 Pt 1):927-35. PubMed ID: 12297840
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1.
    Satoh S, Daigo Y, Furukawa Y, Kato T, Miwa N, Nishiwaki T, Kawasoe T, Ishiguro H, Fujita M, Tokino T, Sasaki Y, Imaoka S, Murata M, Shimano T, Yamaoka Y, Nakamura Y.
    Nat Genet; 2000 Mar; 24(3):245-50. PubMed ID: 10700176
    [Abstract] [Full Text] [Related]

  • 5. Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas.
    Taniguchi K, Roberts LR, Aderca IN, Dong X, Qian C, Murphy LM, Nagorney DM, Burgart LJ, Roche PC, Smith DI, Ross JA, Liu W.
    Oncogene; 2002 Jul 18; 21(31):4863-71. PubMed ID: 12101426
    [Abstract] [Full Text] [Related]

  • 6. The beta-catenin pathway is activated in focal nodular hyperplasia but not in cirrhotic FNH-like nodules.
    Rebouissou S, Couchy G, Libbrecht L, Balabaud C, Imbeaud S, Auffray C, Roskams T, Bioulac-Sage P, Zucman-Rossi J.
    J Hepatol; 2008 Jul 18; 49(1):61-71. PubMed ID: 18466996
    [Abstract] [Full Text] [Related]

  • 7. Accumulation of beta-catenin protein and mutations in exon 3 of beta-catenin gene in gastrointestinal carcinoid tumor.
    Fujimori M, Ikeda S, Shimizu Y, Okajima M, Asahara T.
    Cancer Res; 2001 Sep 15; 61(18):6656-9. PubMed ID: 11559529
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Aberrant nuclear localization and gene mutation of beta-catenin in low-grade adenocarcinoma of fetal lung type: up-regulation of the Wnt signaling pathway may be a common denominator for the development of tumors that form morules.
    Nakatani Y, Masudo K, Miyagi Y, Inayama Y, Kawano N, Tanaka Y, Kato K, Ito T, Kitamura H, Nagashima Y, Yamanaka S, Nakamura N, Sano J, Ogawa N, Ishiwa N, Notohara K, Resl M, Mark EJ.
    Mod Pathol; 2002 Jun 15; 15(6):617-24. PubMed ID: 12065775
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. No evidence for involvement of beta-catenin and APC in urothelial carcinomas.
    Stoehr R, Krieg RC, Knuechel R, Hofstaedter F, Pilarsky C, Zaak D, Schmitt R, Hartmann A.
    Int J Oncol; 2002 May 15; 20(5):905-11. PubMed ID: 11956582
    [Abstract] [Full Text] [Related]

  • 12. Beta-catenin mutations in hepatocellular carcinoma correlate with a low rate of loss of heterozygosity.
    Legoix P, Bluteau O, Bayer J, Perret C, Balabaud C, Belghiti J, Franco D, Thomas G, Laurent-Puig P, Zucman-Rossi J.
    Oncogene; 1999 Jul 08; 18(27):4044-6. PubMed ID: 10435629
    [Abstract] [Full Text] [Related]

  • 13. Genetic alterations of Wnt signaling pathway-associated genes in hepatocellular carcinoma.
    Kim YD, Park CH, Kim HS, Choi SK, Rew JS, Kim DY, Koh YS, Jeung KW, Lee KH, Lee JS, Juhng SW, Lee JH.
    J Gastroenterol Hepatol; 2008 Jan 08; 23(1):110-8. PubMed ID: 18171349
    [Abstract] [Full Text] [Related]

  • 14. Correlation between protein expression and epigenetic and mutation changes of Wnt pathway-related genes in oral cancer.
    Yeh KT, Chang JG, Lin TH, Wang YF, Chang JY, Shih MC, Lin CC.
    Int J Oncol; 2003 Oct 08; 23(4):1001-7. PubMed ID: 12963979
    [Abstract] [Full Text] [Related]

  • 15. The human T-cell factor-4 gene splicing isoforms, Wnt signal pathway, and apoptosis in renal cell carcinoma.
    Shiina H, Igawa M, Breault J, Ribeiro-Filho L, Pookot D, Urakami S, Terashima M, Deguchi M, Yamanaka M, Shirai M, Kaneuchi M, Kane CJ, Dahiya R.
    Clin Cancer Res; 2003 Jun 08; 9(6):2121-32. PubMed ID: 12796377
    [Abstract] [Full Text] [Related]

  • 16. Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features.
    Wei Y, Van Nhieu JT, Prigent S, Srivatanakul P, Tiollais P, Buendia MA.
    Hepatology; 2002 Sep 08; 36(3):692-701. PubMed ID: 12198663
    [Abstract] [Full Text] [Related]

  • 17. Mutations and elevated transcriptional activity of conductin (AXIN2) in hepatoblastomas.
    Koch A, Weber N, Waha A, Hartmann W, Denkhaus D, Behrens J, Birchmeier W, von Schweinitz D, Pietsch T.
    J Pathol; 2004 Dec 08; 204(5):546-54. PubMed ID: 15538750
    [Abstract] [Full Text] [Related]

  • 18. Beta-catenin accumulation in the progression of human hepatocarcinogenesis correlates with loss of E-cadherin and accumulation of p53, but not with expression of conventional WNT-1 target genes.
    Prange W, Breuhahn K, Fischer F, Zilkens C, Pietsch T, Petmecky K, Eilers R, Dienes HP, Schirmacher P.
    J Pathol; 2003 Oct 08; 201(2):250-9. PubMed ID: 14517842
    [Abstract] [Full Text] [Related]

  • 19. Novel colon cancer cell lines leading to better understanding of the diversity of respective primary cancers.
    Vécsey-Semjén B, Becker KF, Sinski A, Blennow E, Vietor I, Zatloukal K, Beug H, Wagner E, Huber LA.
    Oncogene; 2002 Jul 11; 21(30):4646-62. PubMed ID: 12096341
    [Abstract] [Full Text] [Related]

  • 20. Immunohistochemistry of cyclin D1 and beta-catenin, and mutational analysis of exon 3 of beta-catenin gene in parathyroid adenomas.
    Ikeda S, Ishizaki Y, Shimizu Y, Fujimori M, Ojima Y, Okajima M, Sugino K, Asahara T.
    Int J Oncol; 2002 Mar 11; 20(3):463-6. PubMed ID: 11836555
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.